Prognostic relevance of ARFI elastography in comparison to liver histology and the FIB-4 score.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00031674

Enrollment

573

Registered

2023-04-26

Start date

2018-12-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K74.0

Interventions

Group 1: Patients with an elastography examination of the liver between 2010 and 2012, a liver biopsy, a FIB-4 score and a follow up of 5 years at the Erlangen University Hospital were included in the

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Correct ARFI measurement (at least 5 measurements) of the right liver lobe, an evaluable liver biopsy at an interval of max. 1 year to the ARFI measurement, valid FIB-4 score at the time of ARFI measurement, follow-up patient data of at least 5 years after ARFI measurement

Exclusion criteria

Exclusion criteria: Inadequate ARFI measurement, liver biopsy not performed, no complete follow-up data during the observation period, missing FIB-4 score

Design outcomes

Primary

Measure	Time frame
Liver related survival	—

Secondary

Measure	Time frame
Overall survival, occurrence of HCC, occurrence of liver decompensation/variceal bleeding	—

Countries

Germany

Contacts

Public ContactLukas Pfeifer

Klinik für Gastroenterologie und interventionelle Endoskopie, Krankenhaus Barmherzige Brüder Regensburg

lukas.pfeifer@barmherzige-regensburg.de+4994136992062

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026